News & Events

• January 1, 2017
  

  Evaluating the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Results from the quantitative pilot study

  Liepa AM, Bushnell DM, Atkinson TM, DeBusk K, McCarrier KP, Martin ML, et al. Evaluating the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Results from the quantitative pilot study. Journal of Thoracic Oncology. 2017;12(1S):S666.

• January 1, 2017
  

  Preclinical Biomarker Qualification

  Sauer JM, Porter AC, Biomarker Programs, Predictive Safety Testing Consortium. Preclinical Biomarker Qualification. Experimental Biology and Medicine (Maywood, NJ). 2017 Jan 1.

• December 1, 2016
  

  Interpretation of verbal descriptors for response options commonly used in verbal rating scales in patient-reported outcome instruments

• November 3, 2016
  

  Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (Including Biological Products) in Neonates

  Ward RM, Benjamin D, Barrett JS, Allegaert K, Portman R, Davis JM, Turner MA, and the International Neonatal Consortium. Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (including Biological Products) in Neonates. Pediatric Research. 2017 Mar 1....
• October 24, 2016
  

  Advancing Tuberculosis Drug Regimen Development through Innovative Quantitative Translational Pharmacology Methods and Approaches

  Hanna D, Romero K, Schito M. Advancing Tuberculosis Drug Regimen Development through Innovative Quantitative Translational Pharmacology Methods and Approaches. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2016 Oct 24;56:208–11.